Vanda Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 8, 2012
Conference Call and Webcast to Follow
WASHINGTON, April 18, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will release results for the first quarter of 2012, on Tuesday, May 8, 2012, before the market opens.
The Company will host a conference call at 10:00 AM ET on Tuesday, May 8, 2012 during which Vanda management will discuss the financial results. To participate in the conference call, please dial 1-866-314-4865 (domestic) or 1-617-213-8050 (international) and use passcode 62288061.
The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Tuesday, May 8, 2012, beginning at 12:00 PM ET and will be accessible until Tuesday, May 15, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The passcode number is 20166070.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Senior Communications Manager
Vanda Pharmaceuticals Inc.
SOURCE Vanda Pharmaceuticals Inc.
More by this Source
Vanda Pharmaceuticals Reports First Quarter 2013 Results
May 09, 2013, 06:55 ET
Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
Apr 18, 2013, 07:00 ET
Vanda Pharmaceuticals Appoints Dr. Paolo Baroldi As Chief Medical Officer
Apr 17, 2013, 19:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.